<DOC>
	<DOC>NCT00868296</DOC>
	<brief_summary>The purpose of this study is to provide additional information on safety and tolerability after multiple does of pantoprazole. Only patients who successfully completed the 3001B3-331 study (NCT00362609) or 3001B3-333 study (NCT00259012) are eligible to participate in this study.</brief_summary>
	<brief_title>Open Label Safety Study of Enteric-Coated Spheroid Suspension in Infants Aged Less Than 12 Months With Presumed Gastroesophageal Reflux Disease (GERD)</brief_title>
	<detailed_description />
	<mesh_term>Gastroesophageal Reflux</mesh_term>
	<mesh_term>Pantoprazole</mesh_term>
	<criteria>Successful completion of the 3001B3331 study (NCT00362609) or 3001B3333 study (NCT00259012) Study. Patients requiring chronic use of warfarin, carbamepazine, or phenytoin.</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>12 Months</maximum_age>
	<verification_date>April 2010</verification_date>
	<keyword>Safety</keyword>
</DOC>